HOPE BROWN: Open Payments
NPI 1538527510 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,504 in 112 payments from 23 companies in 2025. Trend: 2023 $1,650 · 2024 $2,781 · 2025 $2,504
Food & beverage: $2,404Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $447 |
| Novartis Pharmaceuticals Corporation | 16 | $375 |
| UCB, Inc. | 8 | $225 |
| GENZYME CORPORATION | 7 | $216 |
| ABBVIE INC. | 10 | $204 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $154 |
| Galderma Laboratories, L.P. | 6 | $108 |
| PFIZER INC. | 5 | $89 |
| LEO Pharma Inc. | 4 | $85 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $74 |
Products named: TREMFYA, COSENTYX, DUPIXENT, Bimzelx, ILUMYA, RINVOQ, NEMLUVIO, SKYRIZI.
Industry payments across TN — which companies pay providers there.
